🇺🇸 LGND — Ligand Pharmaceuticals Incorporated

Salud Compra fuerte
← Volver

Precio actual

307,02 USD

Máx. histórico

322,75

3 días

Split 1603:1000 del 02/11/2022

Caída desde máximo

-4,87%

Rango 52 semanas

175,89 – 326,63

Variación hoy

-4,87%

Cierre anterior

322,75

Rango de hoy

306,17 – 324,95

Volumen hoy

265.433

Peor caída histórica

-93,34%

06/03/2000 → 19/11/2008

Recuperado en 2694 días

Volatilidad anualizada ⓘ

59,76%

Información
Nombre completo
Ligand Pharmaceuticals Incorporated
Divisa
USD
Mercado
NasdaqGM
Sector
Salud
Industria
Biotechnology
Empleados
47
PER ⓘ
32,35 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
350,92 USD (puede no estar actualizado)
Primera cotización
18/11/1992
Precio actualizado
hace 23 horas
Sobre la empresa

Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.

Dividendos repartidos Total últimos 12 meses: 0,0000 USD · Yield: 0,00%
Fecha de pago Importe por participación
03/04/2007 9,3575 USD
Splits Registrados en el histórico de precios
Fecha Ratio
02/11/2022 1603:1000
19/11/2010 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
08/12/1993 45,85 45,85 43,04 43,04 +0,00% 6,12% 775
07/12/1993 43,04 44,45 43,04 43,04 -3,16% 3,26% 1.817
06/12/1993 44,45 44,92 43,04 44,45 +3,26% 4,21% 1.710
03/12/1993 44,45 45,85 43,04 43,04 +0,00% 6,32% 1.469
02/12/1993 43,04 43,04 43,04 43,04 -2,13% 0,00% 294
01/12/1993 44,92 45,85 43,04 43,98 +2,17% 6,25% 3.366
30/11/1993 43,98 45,85 43,04 43,04 -4,17% 6,38% 1.550
29/11/1993 43,98 45,85 42,11 44,92 +6,67% 8,51% 668
26/11/1993 41,17 42,11 41,17 42,11 +0,00% 2,27% 1.683
24/11/1993 40,24 42,11 40,24 42,11 +0,00% 4,65% 2.084
23/11/1993 40,24 42,11 40,24 42,11 +4,65% 4,65% 668
22/11/1993 40,24 42,11 40,24 40,24 -2,27% 4,65% 7.534
19/11/1993 40,24 41,17 40,24 41,17 +0,00% 2,33% 8.282
18/11/1993 40,24 41,17 40,24 41,17 -4,35% 2,33% 1.443
17/11/1993 42,11 43,04 40,24 43,04 +8,24% 6,67% 1.443
16/11/1993 39,30 41,17 38,37 39,77 -3,41% 7,14% 7.374
15/11/1993 41,17 41,17 38,37 41,17 +1,15% 6,82% 935
12/11/1993 39,30 40,70 38,37 40,70 +3,57% 5,95% 9.217
11/11/1993 36,49 39,30 36,49 39,30 +5,00% 7,69% 1.389
10/11/1993 39,30 39,30 36,49 37,43 +2,56% 7,14% 1.069
09/11/1993 36,49 37,43 36,49 36,49 +0,00% 2,56% 5.557
08/11/1993 36,49 36,49 36,49 36,49 -2,50% 0,00% 187
05/11/1993 40,24 40,24 36,49 37,43 -9,09% 9,30% 7.053
04/11/1993 43,04 44,92 40,24 41,17 -4,35% 10,87% 9.832
03/11/1993 43,04 43,04 43,04 43,04 +0,00% 0,00% 695
02/11/1993 45,85 45,85 43,04 43,04 +0,00% 6,12% 4.595
01/11/1993 45,85 45,85 43,04 43,04 -6,12% 6,12% 321
29/10/1993 45,85 45,85 44,45 45,85 +6,52% 3,06% 2.164
28/10/1993 45,85 45,85 43,04 43,04 +0,00% 6,12% 294
27/10/1993 43,04 43,04 43,04 43,04 +0,00% 0,00% 962